OMERS Administration Corp’s ResMed RMD Stock Holding History

OMERS Administration Corp’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.31M	Buy	22,106 +2,815	+15%	+$583K	0.03%	357
2026 Q1	$4.33M	Buy	19,291 +4,985	+35%	+$1.24M	0.03%	282
2025 Q4	$3.45M	Buy	14,306 +1,586	+12%	+$406K	0.02%	249
2025 Q3	$3.48M	Sell	12,720 -700	-5%	-$191K	0.02%	245
2025 Q2	$3.46M	Sell	13,420 -300	-2%	-$71.6K	0.03%	217
2025 Q1	$3.07M	Buy	13,720 +1,849	+16%	+$432K	0.03%	243
2024 Q4	$2.71M	Sell	11,871 -2,518	-17%	-$606K	0.02%	257
2024 Q3	$3.51M	Hold	14,389	–	–	0.03%	219
2024 Q2	$2.75M	Buy	+14,389	New	+$2.92M	0.03%	280
2018 Q1	–	Sell	-41,900	Closed	-$3.55M	–	495
2017 Q4	$3.55M	Buy	+41,900	New	+$3.46M	0.04%	193
2016 Q4	–	Sell	-48,800	Closed	-$3.16M	–	503
2016 Q3	$3.16M	Sell	48,800 -1,800	-4%	-$120K	0.06%	191
2016 Q2	$3.2M	Buy	50,600 +38,000	+302%	+$2.24M	0.07%	179
2016 Q1	$729K	Buy	+12,600	New	+$713K	0.02%	348
2015 Q3	–	Sell	-5,300	Closed	-$299K	–	471
2015 Q2	$299K	Buy	+5,300	New	+$335K	0.01%	381

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

OMERS Administration Corp's RMD Position: Q2 2026 in Review

OMERS Administration Corp increased its ResMed (RMD) stake by 15% in Q2 2026, buying an estimated $583K and bringing the position to 22,106 shares worth $4.31M. The position accounts for 0.03% of the portfolio, ranked #357.

OMERS Administration Corp first reported a position in RMD in Q2 2015 and has held it in 14 quarters since. The position peaked at $4.33M in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

OMERS Administration Corp held 22,106 shares of ResMed worth $4.31M as of Q2 2026.
OMERS Administration Corp bought 2,815 ResMed shares in Q2 2026, an estimated $583K.
ResMed made up 0.03% of OMERS Administration Corp's portfolio in Q2 2026, its #357 holding.
OMERS Administration Corp first reported a position in ResMed in Q2 2015 and has held it in 14 quarters since.
OMERS Administration Corp's ResMed position peaked at $4.33M in Q1 2026.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.